The funding will be used to expand the firm's global services, enhance its core platforms, and accelerate the development of pathology foundational models.
FDA officials said that the draft guidance is meant to address recommendations from two reports on the agency's response to COVID-19.
The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.
The TissueCypher assay is designed to identify patients with Barrett's esophagus who are at risk of progressing to esophageal cancer.